News
![Vedanta Biosciences Expands Network of Clinical Collaborations Supporting Development of Microbiome Therapeutics for Cancer Immunotherapy](https://labcentralorg.blob.core.windows.net/labcentralorg/images/Article-images/_eventBanner/113993/Vedanta-Biosciences-Expands-Network-of-Clinical-Collaborations-Supporting-Development-of-Microbiome-Therapeutics-for-Cancer-Immunotherapy.webp?v=1714799155)
Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs
Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs